Multidrug-Resistant Bacterial Sepsis and Inferior Vena Cava Thrombosis in Liver Transplant Recipients Used Synthetic Vascular Graft: Three Fatal Cases

dc.authoridYilmaz, Sezai/0000-0002-8044-0297
dc.authoridince, volkan/0000-0002-0714-490X
dc.authoridKose, Adem/0000-0002-1853-1243
dc.authoridozdemir, fatih/0000-0003-0292-3602
dc.authoridBAYINDIR, Yasar/0000-0003-3930-774X
dc.authorwosidYilmaz, Sezai/ABI-2323-2020
dc.authorwosidince, volkan/M-7325-2017
dc.authorwosidKose, Adem/AAD-1226-2020
dc.authorwosidozdemir, fatih/HJI-7585-2023
dc.contributor.authorKose, A.
dc.contributor.authorInce, V
dc.contributor.authorOzdemir, F.
dc.contributor.authorKutlu, R.
dc.contributor.authorBayindir, Y.
dc.contributor.authorYilmaz, S.
dc.date.accessioned2024-08-04T20:49:20Z
dc.date.available2024-08-04T20:49:20Z
dc.date.issued2020
dc.departmentİnönü Üniversitesien_US
dc.description.abstractSynthetic vascular grafts are commonly used in liver transplantation. Thrombosis is a possible complication of using expanded polytetrafluoroethylene (e-PTFE) grafts. Herein, we report on 3 cases of liver recipients who died of intermittent sepsis episodes emerged concurrently with the thrombosis in synthetic vascular grafts and inferior vena cava (IVC) vein. Right lobe liver transplantation from living donors was performed for 3 patients by using e-PTFE grafts between the liver and IVC. Although heparin had been administered, thrombosis was developed in vascular graft and IVC extending to the right atrium; it was developed within 1-4 months of transplantations. All 3 patients suffered from recurrent sepsis episodes (4, 5, and 6 attacks for each patient) by different multidrug-resistant bacterial species. Treatment attempts including thrombolytic and antimicrobial drugs made, and surgical, endoscopic and radiological interventions could not resolve the clinical situation. The patients died of septic complications. We concluded that severe recurrent sepsis attacks may develop in liver transplant recipients when IVC and synthetic vascular graft were thrombosed. Removing the e-PTFE graft may be benefit for the treatment.en_US
dc.identifier.endpage201en_US
dc.identifier.issn2008-6490
dc.identifier.issn2008-6482
dc.identifier.issue4en_US
dc.identifier.pmid33335700en_US
dc.identifier.scopus2-s2.0-85101731338en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage196en_US
dc.identifier.urihttps://hdl.handle.net/11616/99789
dc.identifier.volume11en_US
dc.identifier.wosWOS:000582461300005en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherAvicenna Organ Transplant Centeren_US
dc.relation.ispartofInternational Journal of Organ Transplantation Medicineen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectSynthetic graften_US
dc.subjectLiver transplantationen_US
dc.subjectVenous thrombosisen_US
dc.subjectSepsisen_US
dc.titleMultidrug-Resistant Bacterial Sepsis and Inferior Vena Cava Thrombosis in Liver Transplant Recipients Used Synthetic Vascular Graft: Three Fatal Casesen_US
dc.typeArticleen_US

Dosyalar